InfuSystem Announces Appointment of Carrie Lachance as President

ROCHESTER HILLS, Michigan, March 02, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today announced that Carrie Lachance has been appointed as President in addition to her current role as Chief Operating Officer.

Richard DiIorio, chief executive officer of InfuSystem said, “I am pleased to announce the promotion of Carrie Lachance to President of InfuSystem. Carrie has achieved outstanding results exhibiting solid leadership in her role as Chief Operating Officer in managing patient and customer care, including biomedical, clinical, customer service, logistics and revenue cycle management. In the new expanded role as President, Carrie will continue to lead these efforts and work with me to lead the team on the implementation and execution of our growth strategy. I am confident that Carrie’s broad base of health care experience and knowledge is well suited to grow and scale up our two operating platforms – Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME) – with new therapies and products.” 

Mr. DiIorio continued, “The appointment of Carrie as President continues my commitment to build a strong leadership team with deep industry knowledge and proven leadership experience. I am dedicated to our long-term goal of making InfuSystem a leading health care services company. With the recent key leadership additions of Barry Steele as Chief Financial Officer, Jeannine Lombardi Sheehan as Chief Administrative Officer and Tom Ruiz as Chief Commercial Officer, I believe the Company is well positioned to deliver the industry’s best patient care and customer service as we work to expand our portfolio with new therapies in the coming years.”

Carrie Lachance joined InfuSystem in 2010 and serves as the Company’s Chief Operating Officer (“COO”). Prior to her appointment as COO, Carrie held numerous positions with the Company including management roles in Clinical Resources and Clinical Sales. Carrie brings extensive clinical knowledge from more than 20 years in the medical field. Her medical career began in 1996 as a Hospital Corpsman in the U.S. Navy and Naval Reserves. Her nursing knowledge and experience in both the hospital and clinic settings, as well as oncology medical sales and product development, have been instrumental in promoting positive relations with partners, vendors, and distributors.